Back to Search Start Over

Drug companies are fined more than £260m for overcharging NHS for hydrocortisone pills

Drug companies are fined more than £260m for overcharging NHS for hydrocortisone pills

Authors :
Abi Rimmer
Source :
BMJ (Clinical research ed.). 374
Publication Year :
2021

Abstract

The Competition and Markets Authority has fined drug companies over £260m (€305m; $360m) for inflating the price of hydrocortisone tablets by more than 10 000%. The rising costs meant that the amount the NHS paid for a single pack of 10 mg hydrocortisone tablets rose from 70 p in April 2008 to £88 by March 2016, the CMA said.1 For the 20 mg version the price rose from £1.07 to £102.74 a pack over the same period. Before April 2008 the NHS was spending around £500 000 a year on hydrocortisone tablets, the CMA said. This had risen to …

Details

ISSN :
17561833
Volume :
374
Database :
OpenAIRE
Journal :
BMJ (Clinical research ed.)
Accession number :
edsair.doi.dedup.....96930e5a4fb1b18a7d67efff9981c7a8